Autologous platelet concentrate for the treatment of macular hole: a systematic review and meta-analysis

ABSTRACT Autologous platelet concentrates are rich in growth factors and have shown potential for high anatomical success rates in macular hole treatment. However, no systematic review has yet assessed its impact. Therefore, this study aimed to conduct a comprehensive review and meta-analysis on the...

Full description

Saved in:
Bibliographic Details
Main Authors: Dillan Cunha Amaral, Mário Luiz Ribeiro Monteiro, Milton Ruiz Alves, Ivar Vargas Belizario, Lucas de Sousa Tebicherane, Raíza Jacometti, José Eduardo Ferreira Manso, Agma Juci Machado Traina, Ricardo Noguera Louzada
Format: Article
Language:English
Published: Instituto Israelita de Ensino e Pesquisa Albert Einstein 2024-12-01
Series:Einstein (São Paulo)
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1679-45082024000100411&lng=en&tlng=en
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850114306480275456
author Dillan Cunha Amaral
Mário Luiz Ribeiro Monteiro
Milton Ruiz Alves
Ivar Vargas Belizario
Lucas de Sousa Tebicherane
Raíza Jacometti
José Eduardo Ferreira Manso
Agma Juci Machado Traina
Ricardo Noguera Louzada
author_facet Dillan Cunha Amaral
Mário Luiz Ribeiro Monteiro
Milton Ruiz Alves
Ivar Vargas Belizario
Lucas de Sousa Tebicherane
Raíza Jacometti
José Eduardo Ferreira Manso
Agma Juci Machado Traina
Ricardo Noguera Louzada
author_sort Dillan Cunha Amaral
collection DOAJ
description ABSTRACT Autologous platelet concentrates are rich in growth factors and have shown potential for high anatomical success rates in macular hole treatment. However, no systematic review has yet assessed its impact. Therefore, this study aimed to conduct a comprehensive review and meta-analysis on the comparative efficacy and safety of autologous platelet concentrates in treating macular hole. A systematic review of the literature on autologous platelet concentrate therapy for macular hole was conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines on September 9, 2023. Databases, including PubMed, the Cochrane Library, Web of Science, and Embase, were queried. A meta-analysis of random effects was performed. Efficacy was evaluated through anatomical closure, reopening of the macular hole at 6 months, average improvement of 2 lines, and visual field loss. Safety was evaluated by monitoring complications. A systematic search of multiple databases identified six studies (three randomized controlled trials and three non-randomized cohort studies) involving 616 patients (626 eyes). Autologous platelets concentrate therapy significantly improved macular hole closure compared to that in the controls (OR=4.35; 95%CI=2.08-9.10; p<0.0001; I²=9%). No significant differences were observed in hole reopening at 6 months, post-operative visual acuity improvement by 2 lines or more, or visual field loss between autologous platelets concentrate and control groups. The overall complication rates were similar between groups. Thus, autologous platelet concentrate therapy shows promise for promoting macular hole closure, particularly in smaller holes. Further research with standardized protocols, prolonged follow-ups, and larger sample sizes is needed to fully understand its benefits and limitations in macular hole closure. Prospero database registration: (https://www.crd.york.ac.uk/prospero/) under ID CRD42023455815.
format Article
id doaj-art-d5762d3f1ce24ddebb7dc06cc4ca86c1
institution OA Journals
issn 2317-6385
language English
publishDate 2024-12-01
publisher Instituto Israelita de Ensino e Pesquisa Albert Einstein
record_format Article
series Einstein (São Paulo)
spelling doaj-art-d5762d3f1ce24ddebb7dc06cc4ca86c12025-08-20T02:36:54ZengInstituto Israelita de Ensino e Pesquisa Albert EinsteinEinstein (São Paulo)2317-63852024-12-012210.31744/einstein_journal/2024rw0832Autologous platelet concentrate for the treatment of macular hole: a systematic review and meta-analysisDillan Cunha Amaralhttps://orcid.org/0009-0002-7948-154XMário Luiz Ribeiro Monteirohttps://orcid.org/0000-0002-7281-2791Milton Ruiz Alveshttps://orcid.org/0000-0001-6759-5289Ivar Vargas Belizariohttps://orcid.org/0000-0001-5970-2283Lucas de Sousa Tebicheranehttps://orcid.org/0009-0001-1824-7592Raíza Jacomettihttps://orcid.org/0009-0005-4524-8661José Eduardo Ferreira Mansohttps://orcid.org/0000-0001-9694-7415Agma Juci Machado Trainahttps://orcid.org/0000-0003-4929-7258Ricardo Noguera Louzadahttps://orcid.org/0000-0002-9610-5768ABSTRACT Autologous platelet concentrates are rich in growth factors and have shown potential for high anatomical success rates in macular hole treatment. However, no systematic review has yet assessed its impact. Therefore, this study aimed to conduct a comprehensive review and meta-analysis on the comparative efficacy and safety of autologous platelet concentrates in treating macular hole. A systematic review of the literature on autologous platelet concentrate therapy for macular hole was conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines on September 9, 2023. Databases, including PubMed, the Cochrane Library, Web of Science, and Embase, were queried. A meta-analysis of random effects was performed. Efficacy was evaluated through anatomical closure, reopening of the macular hole at 6 months, average improvement of 2 lines, and visual field loss. Safety was evaluated by monitoring complications. A systematic search of multiple databases identified six studies (three randomized controlled trials and three non-randomized cohort studies) involving 616 patients (626 eyes). Autologous platelets concentrate therapy significantly improved macular hole closure compared to that in the controls (OR=4.35; 95%CI=2.08-9.10; p<0.0001; I²=9%). No significant differences were observed in hole reopening at 6 months, post-operative visual acuity improvement by 2 lines or more, or visual field loss between autologous platelets concentrate and control groups. The overall complication rates were similar between groups. Thus, autologous platelet concentrate therapy shows promise for promoting macular hole closure, particularly in smaller holes. Further research with standardized protocols, prolonged follow-ups, and larger sample sizes is needed to fully understand its benefits and limitations in macular hole closure. Prospero database registration: (https://www.crd.york.ac.uk/prospero/) under ID CRD42023455815.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1679-45082024000100411&lng=en&tlng=enMacular holeAutologous plateletVitrectomyRetinal perforations
spellingShingle Dillan Cunha Amaral
Mário Luiz Ribeiro Monteiro
Milton Ruiz Alves
Ivar Vargas Belizario
Lucas de Sousa Tebicherane
Raíza Jacometti
José Eduardo Ferreira Manso
Agma Juci Machado Traina
Ricardo Noguera Louzada
Autologous platelet concentrate for the treatment of macular hole: a systematic review and meta-analysis
Einstein (São Paulo)
Macular hole
Autologous platelet
Vitrectomy
Retinal perforations
title Autologous platelet concentrate for the treatment of macular hole: a systematic review and meta-analysis
title_full Autologous platelet concentrate for the treatment of macular hole: a systematic review and meta-analysis
title_fullStr Autologous platelet concentrate for the treatment of macular hole: a systematic review and meta-analysis
title_full_unstemmed Autologous platelet concentrate for the treatment of macular hole: a systematic review and meta-analysis
title_short Autologous platelet concentrate for the treatment of macular hole: a systematic review and meta-analysis
title_sort autologous platelet concentrate for the treatment of macular hole a systematic review and meta analysis
topic Macular hole
Autologous platelet
Vitrectomy
Retinal perforations
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1679-45082024000100411&lng=en&tlng=en
work_keys_str_mv AT dillancunhaamaral autologousplateletconcentrateforthetreatmentofmacularholeasystematicreviewandmetaanalysis
AT marioluizribeiromonteiro autologousplateletconcentrateforthetreatmentofmacularholeasystematicreviewandmetaanalysis
AT miltonruizalves autologousplateletconcentrateforthetreatmentofmacularholeasystematicreviewandmetaanalysis
AT ivarvargasbelizario autologousplateletconcentrateforthetreatmentofmacularholeasystematicreviewandmetaanalysis
AT lucasdesousatebicherane autologousplateletconcentrateforthetreatmentofmacularholeasystematicreviewandmetaanalysis
AT raizajacometti autologousplateletconcentrateforthetreatmentofmacularholeasystematicreviewandmetaanalysis
AT joseeduardoferreiramanso autologousplateletconcentrateforthetreatmentofmacularholeasystematicreviewandmetaanalysis
AT agmajucimachadotraina autologousplateletconcentrateforthetreatmentofmacularholeasystematicreviewandmetaanalysis
AT ricardonogueralouzada autologousplateletconcentrateforthetreatmentofmacularholeasystematicreviewandmetaanalysis